These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36628274)

  • 1. PYY modulates the tumorigenesis and progression of colorectal cancer unveiled by proteomics.
    Jing F; Liu G; Zhang R; Xue W; Lin J; Zhu H; Zhu Y; Wu C; Luo Y; Chen T; Li S; Bao M
    Am J Cancer Res; 2022; 12(12):5500-5515. PubMed ID: 36628274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer.
    Li XN; Wang ZJ; Ye CX; Zhao BC; Li ZL; Yang Y
    J Exp Clin Cancer Res; 2018 Dec; 37(1):325. PubMed ID: 30591054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement C5 is a novel biomarker for liver metastasis of colorectal cancer.
    Chang H; Jin L; Xie P; Zhang B; Yu M; Li H; Liu S; Yan J; Zhou B; Li X; Xu Y; Xiao Y; Ye Q; Guo L
    J Gastrointest Oncol; 2022 Oct; 13(5):2351-2365. PubMed ID: 36388659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression.
    Teng D; Xia S; Hu S; Yan Y; Liu B; Yang Y; Du X
    Comput Intell Neurosci; 2022; 2022():7179733. PubMed ID: 35795731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated proteomic and phosphoproteomic analysis for characterization of colorectal cancer.
    Zhu H; Li Y; Guo J; Feng S; Ge H; Gu C; Wang M; Nie R; Li N; Wang Y; Wang H; Zhong J; Qian X; He G
    J Proteomics; 2023 Mar; 274():104808. PubMed ID: 36596410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
    Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
    Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Corrigendum] LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL‑6 and TNF‑α.
    Xu J; Qian J; Zhang W; Chen E; Zhang G; Cao G; Wang F; Shen X; Zhou W; Song Z
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33882644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OTOP2, Inversely Modulated by miR-3148, Inhibits CRC Cell Migration, Proliferation and Epithelial-Mesenchymal Transition: Evidence from Bioinformatics Data Mining and Experimental Verification.
    Guo S; Sun Y
    Cancer Manag Res; 2022; 14():1371-1384. PubMed ID: 35418782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
    Milone MR; Pucci B; Colangelo T; Lombardi R; Iannelli F; Colantuoni V; Sabatino L; Budillon A
    Mol Oncol; 2016 Oct; 10(8):1344-62. PubMed ID: 27499265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis.
    Sethi MK; Thaysen-Andersen M; Kim H; Park CK; Baker MS; Packer NH; Paik YK; Hancock WS; Fanayan S
    J Proteomics; 2015 Aug; 126():54-67. PubMed ID: 26054784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA Ftx regulates the protein expression profile in HCT116 human colon cancer cells.
    Jia R; Song L; Fei Z; Qin C; Zhao Q
    Proteome Sci; 2022 Apr; 20(1):7. PubMed ID: 35490216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
    Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
    Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
    [No Abstract]   [Full Text] [Related]  

  • 14. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.
    Wang QQ; Zhou YC; Zhou Ge YJ; Qin G; Yin TF; Zhao DY; Tan C; Yao SK
    World J Clin Cases; 2022 Aug; 10(22):7686-7697. PubMed ID: 36158487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
    Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
    Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics study of colorectal cancer and adenomatous polyps identifies TFR1, SAHH, and HV307 as potential biomarkers for screening.
    Tang M; Zeng L; Zeng Z; Liu J; Yuan J; Wu D; Lu Y; Zi J; Ye M
    J Proteomics; 2021 Jul; 243():104246. PubMed ID: 33915303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis.
    Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N
    Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein screening in colorectal cancer based on differentially expressed Tn antigen.
    Wei H; Cheng Z; Ouyang C; Zhang Y; Hu Y; Chen S; Wang C; Lu F; Zhang J; Wang Y; Liu X
    Oncol Rep; 2016 Sep; 36(3):1313-24. PubMed ID: 27432485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
    Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
    J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.